The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients
Open accessAbstract
OBJECTIVE: Evidence-based characterization of the diagnostic and prognostic value of the hematological and immunological markers related to the epidemic of Coronavirus Disease 2019 (COVID-19) is critical to understand the clinical course of the infection and to assess in development and validation of biomarkers. METHODS: Based on systematic search in Web of Science, PubMed, Scopus, and Science Direct up to April 22, 2020, a total of 52 eligible articles with 6,320 laboratory-confirmed COVID-19 cohorts were included. Pairwise comparison between severe versus mild disease, Intensive Care Unit (ICU) versus general ward admission and expired versus survivors were performed for 36 laboratory parameters. The pooled standardized mean difference (SMD) and 95% confidence intervals (CI) were calculated using the DerSimonian Laird method/random effects model and converted to the Odds ratio (OR). The decision tree algorithm was employed to identify the key risk factor(s) attributed to severe COVID-19 disease. RESULTS: Cohorts with elevated levels of white blood cells (WBCs) (OR = 1.75), neutrophil count (OR = 2.62), D-dimer (OR = 3.97), prolonged prothrombin time (PT) (OR = 1.82), fibrinogen (OR = 3.14), erythrocyte sedimentation rate (OR = 1.60), procalcitonin (OR = 4.76), IL-6 (OR = 2.10), and IL-10 (OR = 4.93) had higher odds of progression to severe phenotype. Decision tree model (sensitivity = 100%, specificity = 81%) showed the high performance of neutrophil count at a cut-off value of more than 3.74x109/L for identifying patients at high risk of severe COVID-19. Likewise, ICU admission was associated with higher levels of WBCs (OR = 5.21), neutrophils (OR = 6.25), D-dimer (OR = 4.19), and prolonged PT (OR = 2.18). Patients with high IL-6 (OR = 13.87), CRP (OR = 7.09), D-dimer (OR = 6.36), and neutrophils (OR = 6.25) had the highest likelihood of mortality. CONCLUSIONS: Several hematological and immunological markers, in particular neutrophilic count, could be helpful to be included within the routine panel for COVID-19 infection evaluation to ensure risk stratification and effective management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Cai, Q., Yang, M., Liu, D., Chen, J., Shu, D., Xia, J., Liao, X., Gu, Y., Cai, Q., Yang, Y., et al. (2020) · Engineering · doi:10.1016/j.eng.2020.03.007 · Cited by 1,357
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“A continuous random-effect model was applied using the DerSimonian-Laird (inverse variance) method [16, 17].”
MethodZhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775 · cited 2×
“8) 48% Severity [46] Zhao D 12-March Wuhan China Case-control study 19 7 43.”
BackgroundClinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0950 · Cited by 4,349
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903 · cited 5×
“Ultimately, a total of 52 eligible articles were included for the quantitative synthesis of this meta-analysis study, with 52 records represented single-arm analysis [1, 9, 21–70], 16 records represented two-arms severity analysis [24, 26, 32, 34, 37, 40, 41, 45, 46, 50, 51, 63, 64, 66, 69, 70]; meanwhile, 7 and 4 rec…”
BackgroundResultInfluentialRadiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., Fan, Y., & Zheng, C. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30086-4 · Cited by 3,664
McInnes, M. D. F., Moher, D., Thombs, B. D., McGrath, T. A., Bossuyt, P. M., and the PRISMA-DTA Group, Clifford, T., Cohen, J. F., Deeks, J. J., Gatsonis, C., et al. (2018) · JAMA · doi:10.1001/jama.2017.19163 · Cited by 3,210
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
A Nonparametric “Trim and Fill” Method of Accounting for Publication Bias in Meta-Analysis
Duval, S., & Tweedie, R. (2000) · Journal of the American Statistical Association · doi:10.1080/01621459.2000.10473905 · Cited by 2,955
Kidney disease is associated with in-hospital death of patients with COVID-19
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.005 · Cited by 2,941
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)
Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R. L., Yang, L., et al. (2020) · Radiology · doi:10.1148/radiol.2020200370 · Cited by 2,856
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
Ye, Q., Wang, B., & Mao, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.037 · Cited by 2,761
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Young, B. E., Ong, S. W. X., Kalimuddin, S., Low, J. G., Tan, S. Y., Loh, J., Ng, O.-T., Marimuthu, K., Ang, L. W., Mak, T. M., et al. (2020) · JAMA · doi:10.1001/jama.2020.3204 · Cited by 2,059
Xu, X.-W., Wu, X.-X., Jiang, X.-G., Xu, K.-J., Ying, L.-J., Ma, C.-L., Li, S.-B., Wang, H.-Y., Zhang, S., Gao, H.-N., et al. (2020) · BMJ · doi:10.1136/bmj.m606 · Cited by 2,046
Henry, B. M., de Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0369 · Cited by 1,964 · cited 14×
“established a meta-analysis survey and corroborated this finding with a higher significance of CRP and procalcitonin levels [72].”
BackgroundResultInfluentialCharacteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State
Eastin, C., & Eastin, T. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.002 · Cited by 1,869
Diagnosing COVID-19: The Disease and Tools for Detection
Udugama, B., Kadhiresan, P., Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. C., Chen, H., Mubareka, S., Gubbay, J. B., & Chan, W. C. W. (2020) · ACS Nano · doi:10.1021/acsnano.0c02624 · Cited by 1,754
Lippi, G., Plebani, M., & Henry, B. M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.022 · Cited by 1,706
Quantifying publication bias in meta-analysis
Lin, L., & Chu, H. (2018) · Biometrics · doi:10.1111/biom.12817 · Cited by 1,674
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
Liu, K., Chen, Y., Lin, R., & Han, K. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.005 · Cited by 1,642
COVID-19 infection: the perspectives on immune responses
Shi, Y., Wang, Y., Shao, C., Huang, J., Gan, J., Huang, X., Bucci, E., Piacentini, M., Ippolito, G., & Melino, G. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0530-3 · Cited by 1,594
Glotaran: A Java-Based Graphical User Interface for the R Package TIMP
Snellenburg, J. J., Laptenok, S. P., Seger, R., Mullen, K. M., & Stokkum, I. H. M. V. (2012) · Journal of Statistical Software · doi:10.18637/jss.v049.i03 · Cited by 1,509
Lei, S., Jiang, F., Su, W., Chen, C., Chen, J., Mei, W., Zhan, L.-Y., Jia, Y., Zhang, L., Liu, D., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100331 · Cited by 1,415
The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia
Li, K., Wu, J., Wu, F., Guo, D., Chen, L., Fang, Z., & Li, C. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000672 · Cited by 1,268
Wang, L., He, W., Yu, X., Hu, D., Bao, M., Liu, H., Zhou, J., & Jiang, H. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.019 · Cited by 1,175
Closing the Gap between Methodologists and End-Users: R as a Computational Back-End
Wallace, B. C., Dahabreh, I. J., Trikalinos, T. A., Lau, J., Trow, P., & Schmid, C. H. (2012) · Journal of Statistical Software · doi:10.18637/jss.v049.i05 · Cited by 1,125
Liu, W., Tao, Z.-W., Wang, L., Yuan, M.-L., Liu, K., Zhou, L., Wei, S., Deng, Y., Liu, J., Liu, H.-G., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000775 · Cited by 1,104
MERS, SARS and other coronaviruses as causes of pneumonia
Yin, Y., & Wunderink, R. G. (2018) · Respirology · doi:10.1111/resp.13196 · Cited by 1,095
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., Zhu, Y., Liu, Y., Wang, X., & Wang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25770 · Cited by 1,047
Chen, X., Zhao, B., Qu, Y., Chen, Y., Xiong, J., Feng, Y., Men, D., Huang, Q., Liu, Y., Yang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa449 · Cited by 1,020
Yang, W., Cao, Q., Qin, L., Wang, X., Cheng, Z., Pan, A., Dai, J., Sun, Q., Zhao, F., Qu, J., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.016 · Cited by 989
Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., Lang, C., Huang, D., Sun, Q., Xiong, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25783 · Cited by 982 · cited 1×
“General characteristics of the included studies 247 First Author Year Publication date (dd-mm) Journal name Continent Country Study design Sample size Quality score Reference no Zhu Z 2020 22-April International J of Infectious Diseases Ningbo China Retrospective case study 127 9 [35] Liu X 2020 20-April Acta Pharm Si…”
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China
Mo, P., Xing, Y., Xiao, Y., Deng, L., Zhao, Q., Wang, H., Xiong, Y., Cheng, Z., Gao, S., Liang, K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa270 · Cited by 853
Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review
Di Gennaro, F., Pizzol, D., Marotta, C., Antunes, M., Racalbuto, V., Veronese, N., & Smith, L. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17082690 · Cited by 822
Lechien, J. R., Chiesa‐Estomba, C. M., Place, S., Van Laethem, Y., Cabaraux, P., Mat, Q., Huet, K., Plzak, J., Horoi, M., Hans, S., et al. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13089 · Cited by 800
Clinical progression of patients with COVID-19 in Shanghai, China
Chen, J., Qi, T., Liu, L., Ling, Y., Qian, Z., Li, T., Li, F., Xu, Q., Zhang, Y., Xu, S., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.004 · Cited by 789
Hematologic parameters in patients with COVID‐19 infection
Fan, B. E., Chong, V. C. L., Chan, S. S. W., Lim, G. H., Lim, K. G. E., Tan, G. B., Mucheli, S. S., Kuperan, P., & Ong, K. H. (2020) · American Journal of Hematology · doi:10.1002/ajh.25774 · Cited by 769
Emami, A., Javanmardi, F., Pirbonyeh, N., & Akbari, A. (2020) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v8i1.600 · Cited by 765
Chang, D., Lin, M., Wei, L., Xie, L., Zhu, G., Dela Cruz, C. S., & Sharma, L. (2020) · JAMA · doi:10.1001/jama.2020.1623 · Cited by 697
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 694
Deng, Y., Liu, W., Liu, K., Fang, Y.-Y., Shang, J., Zhou, L., Wang, K., Leng, F., Wei, S., Chen, L., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000824 · Cited by 657
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Lippi, G., & Plebani, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.004 · Cited by 652
Wu, J., Wu, X., Zeng, W., Guo, D., Fang, Z., Chen, L., Huang, H., & Li, C. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000670 · Cited by 629
Wu, J., Liu, J., Zhao, X., Liu, C., Wang, W., Wang, D., Xu, W., Zhang, C., Yu, J., Jiang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa199 · Cited by 626
Lippi, G., Simundic, A.-M., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0285 · Cited by 617
C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early
Tan, C., Huang, Y., Shi, F., Tan, K., Ma, Q., Chen, Y., Jiang, X., & Li, X. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25871 · Cited by 565
Zhao, D., Yao, F., Wang, L., Zheng, L., Gao, Y., Ye, J., Guo, F., Zhao, H., & Gao, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa247 · Cited by 488
Xiong, Y., Sun, D., Liu, Y., Fan, Y., Zhao, L., Li, X., & Zhu, W. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000674 · Cited by 470
Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
Zhu, Z., Cai, T., Fan, L., Lou, K., Hua, X., Huang, Z., & Gao, G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.041 · Cited by 435
Qian, G. Q., Yang, N. B., Ding, F., Ma, A. H. Y., Wang, Z. Y., Shen, Y. F., Shi, C. W., Lian, X., Chu, J. G., Chen, L., et al. (2020) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcaa089 · Cited by 382
Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)
Luo, S., Zhang, X., & Xu, H. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.03.043 · Cited by 348
Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1
Tang, X., Du, R.-H., Wang, R., Cao, T.-Z., Guan, L.-L., Yang, C.-Q., Zhu, Q., Hu, M., Li, X.-Y., Li, Y., et al. (2020) · Chest · doi:10.1016/j.chest.2020.03.032 · Cited by 337
Lo, I. L., Lio, C. F., Cheong, H. H., Lei, C. I., Cheong, T. H., Zhong, X., Tian, Y., & Sin, N. N. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45357 · Cited by 326
Cheng, Z., Lu, Y., Cao, Q., Qin, L., Pan, Z., Yan, F., & Yang, W. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.22959 · Cited by 302
Zhao, M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105982 · Cited by 274
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
Liu, X., Li, Z., Liu, S., Sun, J., Chen, Z., Jiang, M., Zhang, Q., Wei, Y., Wang, X., Huang, Y.-Y., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.008 · Cited by 274
COVID-19, ECMO, and lymphopenia: a word of caution
Henry, B. M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30119-3 · Cited by 267
Eastin, C., & Eastin, T. (2020) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.007 · Cited by 263
Rodriguez-Morales, A. J., Bonilla‐Aldana, D. K., Balbin-Ramon, G. J., Rabaan, A. A., Sah, R., Paniz‐Mondolfi, A., Pagliano, P., & Esposito, S. (2020) · PubMed · Cited by 248
The clinical course and its correlated immune status in COVID-19 pneumonia
He, R., Lu, Z., Zhang, L., Fan, T., Xiong, R., Shen, X., Feng, H., Meng, H., Lin, W., Jiang, W., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104361 · Cited by 241
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
Zhou, W., Liu, Y., Tian, D., Wang, C., Wang, S., Cheng, J., Hu, M., Fang, M., & Gao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0127-9 · Cited by 234
Pathogenesis and treatment of cytokine storm in COVID-19
SOY, M., KESER, G., & ATAGÜNDÜZ, P. (2021) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2105-37 · Cited by 210
Coronavirus disease 2019: initial chest CT findings
Zhou, Z., Guo, D., Li, C., Fang, Z., Chen, L., Yang, R., Li, X., & Zeng, W. (2020) · European Radiology · doi:10.1007/s00330-020-06816-7 · Cited by 184
Chen, Z., Fan, H., Cai, J., Li, Y., Wu, B., Hou, Y., Xu, S., Zhou, F., Liu, Y., Xuan, W., et al. (2020) · European Journal of Radiology · doi:10.1016/j.ejrad.2020.108972 · Cited by 130
Kapadia, M. Z., Park, C. K., Beyene, J., Giglia, L., Maxwell, C., & McDonald, S. D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132650 · Cited by 122 · cited 1×
“A modified version of the Newcastle-Ottawa scale (NOS) was adopted to evaluate the process in terms of queue selection, comparability of queues, and evaluation of results [12, 13].”
MethodAl‐Tawfiq, J. A., & Gautret, P. (2018) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2018.12.003 · Cited by 99
Risk-adapted Treatment Strategy For COVID-19 Patients
Zheng, C., Wang, J., Guo, H., Lu, Z., Ma, Y., Zhu, Y., Xia, D., Wang, Y., He, H., Zhou, J., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.047 · Cited by 89
Hsih, W.-H., Cheng, M.-Y., Ho, M., Chou, C.-H., Lin, P., Chi, C.-Y., Liao, W.-C., Chen, C., Leong, L.-Y., Tien, N., et al. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.03.008 · Cited by 83
Hematologic parameters in patients with COVID ‐19 infection: a reply
Fan, B. E. (2020) · American Journal of Hematology · doi:10.1002/ajh.25847 · Cited by 81
Pierce, C. A. (2007) · Organizational Research Methods · doi:10.1177/1094428106296641 · Cited by 57
Lagier, J. C., Colson, P., Tissot Dupont, H., Salomon, J., Doudier, B., Aubry, C., Gouriet, F., Baron, S., Dudouet, P., Flores, R., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101624 · Cited by 52 · cited 1×
“Other reports indicated that leukopenia, leukocytosis, and lymphopenia have been reported, although lymphopenia appears most common [74, 75].”
BackgroundElshazli, R. M., Toraih, E. A., Elgaml, A., Kandil, E. H., & Fawzy, M. S. (2020) · Gene · doi:10.1016/j.gene.2020.144391 · Cited by 36
Self-citationMeasures of single arm outcome in meta‐analyses of rare events in the presence of competing risks
Andreano, A., Rebora, P., & Valsecchi, M. G. (2015) · Biometrical Journal · doi:10.1002/bimj.201400119 · Cited by 20
Cited by
An immune-based biomarker signature is associated with mortality in COVID-19 patients
Abers, M. S., Delmonte, O. M., Ricotta, E. E., Fintzi, J., Fink, D. L., de Jesus, A. A. A., Zarember, K. A., Alehashemi, S., Oikonomou, V., Desai, J. V., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144455 · Cited by 340
Metadata
- Authors
- Elshazli, R. M., Toraih, E. A., Elgaml, A., El-Mowafy, M., El-Mesery, M., Amin, M. N., Hussein, M. H., Killackey, M. T., Fawzy, M. S., & Kandil, E.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-08-21
- Volume
- 15
- Issue
- 8
- Pages
- e0238160
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W3080244189
- Cited by
- 253
- References
- 91
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.